Arvinas (ARVN) Interest Coverage Ratio (QoQ) (2017 - 2021)
Arvinas (ARVN) Interest Coverage Ratio (QoQ) (2017 - 2021) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Arvinas |
492.16 Mn |
-122.74 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2021 |
87.91% |
| Sep 30, 2021 |
8.86% |
| Jun 30, 2021 |
-148.92% |
| Mar 31, 2021 |
-235.88% |
| Dec 31, 2020 |
60.89% |
| Sep 30, 2020 |
-19.88% |
| Jun 30, 2020 |
-13.12% |
| Mar 31, 2020 |
-2.73% |
| Dec 31, 2019 |
-683.50% |
| Sep 30, 2019 |
129.71% |
| Jun 30, 2019 |
-20.91% |
| Mar 31, 2019 |
2.72% |
| Dec 31, 2018 |
40.00% |
| Sep 30, 2018 |
-32.85% |
| Jun 30, 2018 |
-114.99% |
| Mar 31, 2018 |
13.40% |
| Dec 31, 2017 |
11.67% |
| Sep 30, 2017 |
-1.22% |
| Jun 30, 2017 |
-12.52% |
